Ontology highlight
ABSTRACT:
SUBMITTER: Yin J
PROVIDER: S-EPMC6856592 | biostudies-literature | 2019
REPOSITORIES: biostudies-literature
Yin Jiang J Chen Danyang D Luo Kai K Lu Minying M Gu Yixue Y Zeng Shanshan S Chen Xiangzhou X Song Ying Y Zhang Zhijie Z Zheng Guopei G He Zhimin Z Liu Hao H
Journal of Cancer 20191015 24
Triple-negative breast cancer (TNBC) is a highly aggressive breast cancer subtype and lacks effective targeted therapies. Cancerous inhibitor of protein phosphatase 2A (Cip2a) is an oncogene that is known to inhibit PP2A tumor suppressor activity in human malignancies. We previously demonstrated that Cip2a is a novel target for the treatment of TNBC. However, the functional roles of Cip2a in TNBC progression are still not fully characterized. In this study, we identified that miR-301a is a novel ...[more]